openPR Logo
Press release

ETLog Health GmbH processes waste-management project in Yemen

02-18-2008 03:52 PM CET | Energy & Environment

Press release from: ETLog Health EnviroTech & Logistics GmbH

/ PR Agency: ETLog Health Marketing
Berlin/Sanaa. ETLog Health GmbH is part of the project team engaged in the construction in 2008 of the Al Saleh Medical City in Sanaa. The medical city was initiated by the Yemense ministry for planning and international cooperation and is financed by a private investor from the Middle East.

The Yemeni ministry for planning and international cooperation has commissioned the German firm EPOS Health Consultants with the inspection of the planning phases for the Al Saleh Medical City. Located on the outskirts of Sana, the units on the site will guarantee optimal medical provision for the population in the Sana region. Here, ETLog Health GmbH can call on its long years of expertise in the area of waste, sewage and environmental impact assessment in the health sector. In addition, existing plans will be checked and revised, and their implementation will be monitored. In addition to the area of disposal and the environment, planing, architectural, engineering and medical technology specialists will complete the project team.

Contact PR:
Andrea Schuster | schuster(at)etlog-health.de | www.etlog-health.de
Tel.: ++ 49 (0) 30 | 44 31 87 - 40 | Fax: - 49
ETLog Health EnviroTech & Logistics GmbH | Linienstr. 72 | 10119 Berlin


Please send us a brief message informing us of any publication regarding information contained in this press release as well as a free specimen copy. Thank you very much!

ETLog Health EnviroTech & Logistics GmbH is a specialist provider in the healthcare field. The Berlin-based firm acts worldwide as an advisor to clinics, institutions and ministries regarding the disposal of hospital waste, waste management technology, waste water and aids prevention.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ETLog Health GmbH processes waste-management project in Yemen here

News-ID: 37796 • Views:

More Releases from ETLog Health EnviroTech & Logistics GmbH

Waste seminar in Rumania
Waste seminar in Rumania
Berlin/Constanţa. ETLog Health EnviroTech & Logistics GmbH is to take part as a keynote speaker at a seminar in Rumania to take place in Constanţa in September 2008. The seminar is organized by is the Berlin-based Grüne Liga Berlin e.V. and financed by the Deutschen Bundesstiftung Umwelt. Between 24 – 27 September 2008, a seminar will be hosted within the framework of the project “Environmental tandems – joint design -
ETLog Health GmbH processes waste-management project in Lao
ETLog Health GmbH processes waste-management project in Lao
Berlin/Vientiane. ETLog Health GmbH is part of the project team engaged in Health Care Waste Management in Lao since July 2008 until November 2008. The client of ETLog Health is the Danish company Grontmij | CarlBro. The project was initiated by the Government of Lao PDR and is funded by the World Bank, other donors and technical agencies. Some 33 per cent of its 5.7 million inhabitants
Number of new HIV diagnoses in Germany has continued to rise
Number of new HIV diagnoses in Germany has continued to rise
Berlin. The Robert Koch Institute has announced an increase in the number of HIV infections in 2007. A cure for this deadly disease has still not yet been found. The only protection is education. Ministries, organizations and private firms offer information material on this topic. A good example in the AIDS prevention game “Think Negative!®”, developed with teenagers as the target group. “The number of HIV-infected persons living in
ETLog Health GmbH provides waste-management expertise in Bangladesh
Berlin/Dhaka: Commencing April 2008, ETLog Health GmbH is providing technical assistance in solid waste management to the urban primary health care sector in Bangladesh. The project is being implemented over the next 8 months and is being carried out by a consortium of: Aus Health International Pty Ltd (Australia) and ADSL (Bangladesh) - on behalf of the Asian Development Bank [ADB]. Bangladesh joined the Asian Development Bank (ADB) in

All 4 Releases


More Releases for Sana

Investigation announced for long-term Investors in shares of Sana Biotechnology, …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors of Sana Biotechnology, Inc. Investors who are current long term investors in Sana Biotechnology, Inc. (NASDAQ: SANA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: SANA stocks follows a lawsuit filed against Sana Biotechnology, Inc. over
06-09-2025 | Health & Medicine
Getnews
Sana Therapy, Where Growth Meets Authentic Support
Sana Therapy is a San Francisco-based licensed therapy clinic known for meshing evidence-based techniques with authentic, judgment-free support. Image: https://www.globalnewslines.com/uploads/2025/06/cae7566a5b8663f7358a23f6c6038350.jpg "Heal, Grow, Thrive," reads the motto of Sana Therapy [https://sanatherapy.net/], a rapidly growing US therapy clinic known for helping clients overcome stress, anxiety, depression, and various other forms of adversity. Lizette Martinez, the head therapist and owner of Sana Therapy is heavily versed in a wide range of evidence-based and expressive approaches, including
Sana Biotechnology, Inc. (NASDAQ: SANA) Investor Alert: Deadline in Lawsuit on M …
A deadline is coming up on May 20, 2025 in the lawsuit filed for certain investors of Sana Biotechnology, Inc. (NASDAQ: SANA) over alleged securities laws violations by Sana Biotechnology, Inc. Investors who purchased shares of Sana Biotechnology, Inc. (NASDAQ: SANA) have certain options and there are strict and short deadlines running. Deadline: May 20, 2025. Sana Biotechnology, Inc. (NASDAQ: SANA) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or
Te Sana Unveils Wellness Products to Manage Anxiety and Menopause
Dr. Lisa Cortez pairs wellness products with a meditation center for holistic treatment Image: https://lh7-rt.googleusercontent.com/docsz/AD_4nXcOCIvCg2AFeRxgo1B-1nUxtIUMzfe4LbeVCbLtlhddFfnh4f-_XgZWLBKx9Dsgy5w7d9szHlqcARRp8vRmso6qiSyQ5yzq-13VB-bThMN4NkynmknmAUrjPU1aTpIBEh3dNxluWw?key=kOURNHed4j7TKKqHI8ln9Q HOUSTON - May 7, 2025 - Te Sana has developed a holistic approach to wellness with their Pure Wellness Collection. This collection boasts non-toxic skincare products, therapeutic teas, and mindfully crafted candles for women navigating symptoms of anxiety, perimenopause, and menopause. Te Sana's wellness products are infused with high-quality organic ingredients to support healthy skin and essential
Lawsuit filed for Investors who lost money with shares of Sana Biotechnology, In …
An investor, who purchased shares of Sana Biotechnology, Inc. (NASDAQ: SANA), filed a lawsuit over alleged violations of Federal Securities Laws by Sana Biotechnology, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Sana Biotechnology, Inc. (NASDAQ: SANA) have certain options and for certain investors are short and strict deadlines running. Deadline: May 20, 2025. NASDAQ: SANA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com
Biotech Breakthroughs: Sana Biotechnology (NASDAQ: SANA) Type 1 Diabetes, CS Dia …
For investors seeking high-potential stocks priced under $2, several companies stand out due to their innovative offerings, upcoming developments, or strategic positioning in the market. Here's a look at five noteworthy companies to watch in addition to Sana Biotechnology (NASDAQ: SANA) and CS Diagnostics Corp. (OTCQB: CSDX) in January 2025. Sana Biotechnology (NASDAQ: SANA) announced positive results from its first-in-human Type 1 diabetes study. Using Hypoimmune (HIP) technology, transplanted pancreatic islet